“vertex-pharmaceuticals” Archives

in
Entry Author Date Location
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
Vertex Deals Cancer Drugs to Merck for $230M, Staying True to Plan 01/11/17 Boston
Scangos Surfaces to Lead New Infectious Disease Startup, Vir Biotech 01/06/17 San Francisco
Varmus, Sato on Steering De Blasio’s $500M Plan to Grow NY Biotech 12/30/16 New York
Top Stories of 2016 for Xconomy Boston: Editor’s Picks 12/26/16 Boston
14 For ’17: Key Clinical Data to Watch For Next Year (Part 1) 12/21/16 National
NY Bio Surge Continues as De Blasio Unveils $500M, 10-Year Life Sci Plan 12/13/16 New York
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
Boston Healthtech Lab Links Startups with Hospitals, Bose, & Others 09/14/16 Boston
New Relay Therapeutics Aims Supercomputers, $57M At Protein Motion 09/14/16 Boston
From Art Collecting to Allego: Meet the Busiest CEO in Boston Tech 09/13/16 Boston
Seeking to Join Editas, Intellia, CRISPR Tx Makes Long Awaited IPO Push 09/12/16 Boston
Filing: Moderna Blowing Past Record $450M Round With New $600M Raise 08/29/16 Boston
Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More 08/19/16 National
With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs 07/06/16 Boston
Pronutria Rebrands as Axcella Health, Forms “Nutrition” Subsidiary 06/07/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Spero Rolls up More Antibiotics With Vertex Deal 05/25/16 Boston
With $43.5M Startup Cash, Homology Med Chases New Gene Editing Twist 05/02/16 Boston
“Raw Potential” And Three Other Takeaways from NY’s Life Science Disruptors 03/30/16 New York
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
Precision BioSciences, Chimerix, Spreedly, & More NC Innovation News 02/29/16 Raleigh Durham
Pronutria, Eyeing Clinical Push, Gets $42.5M From Nestle Health 02/23/16 Boston
Proteostasis Cuts Price But Heads to Nasdaq After $50M IPO 02/11/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
CRISPR: The Path to Clinical Trials 01/29/16 Boston
Tech Mogul, Patriots Owner Lavish $73M On Dana-Farber Startup 01/07/16 Boston
Bayer, CRISPR Therapeutics Form $335M+ Gene Editing Venture 12/21/15 Boston
With SQZ Deal, Roche Finally Dips Its Toes into Cell Therapy 12/07/15 Boston
Page 1 of 12 next page »